Publication of Final Terms
Summary by AI BETAClose X
Regulatory Announcement
Royal Bank of Canada
March 16, 2026
Publication of Final Terms
Not for release, publication or distribution, directly or indirectly, in or into the United States.
Royal Bank of Canada today issued EUR1,250,000,000 2.625 per cent. Covered Bonds due March 16, 2029 (the "2029 Covered Bonds") and EUR1,000,000,000 3.000 per cent. Covered Bonds due March 16, 2033 (the "2033 Covered Bonds" and, together with the 2029 Covered Bonds, the "Covered Bonds") pursuant to the €75,000,000,000 Global Covered Bond Programme of Royal Bank of Canada, unconditionally and irrevocably guaranteed as to payments by RBC Covered Bond Guarantor Limited Partnership (the "Programme").
The following documents constitute the final terms dated March 12, 2026, in respect of the 2029 Covered Bonds and the final terms dated March 12, 2026, in respect of the 2033 Covered Bonds (collectively, the "Final Terms") relating to the issue of the Covered Bonds for purpose of Article 8 of Regulation (EU) 2017/1129 and as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (EUWA) and must be read in conjunction with the Prospectus dated July 16, 2024, as supplemented by the 1st Supplementary Prospectus dated August 28, 2025, the 2nd Supplementary Prospectus dated December 19, 2025 and the 3rd Supplementary Prospectus dated February 27, 2026, relating to the Programme (together, the "Prospectus"). Full information on Royal Bank of Canada and the offer of the Covered Bonds is only available on the basis of the combination of the Final Terms and the Prospectus.
The Final Terms have been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Prospectus and the Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus and the Final Terms is not addressed. Prior to relying on the information contained in the Prospectus and the Final Terms you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.
In particular, the Covered Bonds have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") or the securities laws of any state of the United States and may not be offered, sold or delivered, directly or indirectly, in or into the United States or to or for the account or benefit of a "U.S. person" (as defined in Regulation S under the Securities Act). Accordingly, the Covered Bonds will be offered only in offshore transactions to non-U.S. persons in reliance upon Regulation S under the Securities Act. This announcement does not constitute an offer to sell or a solicitation to buy securities in the United States or in any other jurisdiction where such offer or solicitation would be unlawful.
Your right to access this service is conditional upon complying with the above requirement.
MiFID II professionals / UK MiFIR professionals / ECPs-only / No PRIIPs KID - Manufacturer target market (MiFID II product governance / UK MIFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared as not available to retail in EEA and the United Kingdom.
To view the Final Terms in full, please paste the following URL into the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/8223W_1-2026-3-16.pdf
http://www.rns-pdf.londonstockexchange.com/rns/8223W_2-2026-3-16.pdf
For further information, please contact:
Paul Burd
Senior Counsel
Royal Bank of Canada
Telephone Number: (437) 925-9253
Fax Number: (416) 955-2032
Email: paul.burd@rbc.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 9 hours ago Luceco
- 10 hours ago Helios Towers
- 10 hours ago Wise Class A
- 10 hours ago EDX Medical Group Plc
- 10 hours ago Naked Wines